IRIS
CORAZZA, GINO ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.158
AS - Asia 22.548
EU - Europa 18.667
SA - Sud America 2.714
Continente sconosciuto - Info sul continente non disponibili 1.072
AF - Africa 745
OC - Oceania 47
AN - Antartide 1
Totale 80.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.783
CN - Cina 11.754
SG - Singapore 4.754
IE - Irlanda 3.883
DE - Germania 2.510
UA - Ucraina 2.330
FI - Finlandia 2.289
HK - Hong Kong 2.110
BR - Brasile 2.005
RU - Federazione Russa 1.909
IT - Italia 1.862
VN - Vietnam 1.702
SE - Svezia 1.038
FR - Francia 1.036
GB - Regno Unito 838
CA - Canada 675
IN - India 481
ZA - Sudafrica 402
BD - Bangladesh 297
AR - Argentina 240
IQ - Iraq 198
JP - Giappone 189
MX - Messico 170
PL - Polonia 144
TR - Turchia 140
NL - Olanda 134
EC - Ecuador 115
ES - Italia 110
BE - Belgio 108
CO - Colombia 106
PK - Pakistan 93
ID - Indonesia 92
CR - Costa Rica 84
CZ - Repubblica Ceca 82
SA - Arabia Saudita 75
MA - Marocco 74
PH - Filippine 70
VE - Venezuela 68
HN - Honduras 67
IL - Israele 60
JM - Giamaica 59
UZ - Uzbekistan 58
MY - Malesia 56
CL - Cile 54
TT - Trinidad e Tobago 54
JO - Giordania 53
PY - Paraguay 52
TN - Tunisia 52
AT - Austria 51
SV - El Salvador 51
GT - Guatemala 49
CW - ???statistics.table.value.countryCode.CW??? 45
PR - Porto Rico 45
LT - Lituania 44
PT - Portogallo 43
NI - Nicaragua 42
KE - Kenya 41
AZ - Azerbaigian 40
IR - Iran 39
EG - Egitto 37
AU - Australia 34
DZ - Algeria 31
GR - Grecia 30
RO - Romania 30
AE - Emirati Arabi Uniti 28
GP - Guadalupe 27
PE - Perù 27
BO - Bolivia 26
CH - Svizzera 25
AL - Albania 24
EU - Europa 23
LB - Libano 22
KZ - Kazakistan 21
OM - Oman 21
ET - Etiopia 20
NP - Nepal 20
KG - Kirghizistan 19
RS - Serbia 19
MU - Mauritius 18
TH - Thailandia 17
LV - Lettonia 16
UY - Uruguay 16
PS - Palestinian Territory 15
SY - Repubblica araba siriana 15
BY - Bielorussia 14
GE - Georgia 13
KR - Corea 13
MD - Moldavia 13
EE - Estonia 12
NZ - Nuova Zelanda 12
PA - Panama 12
BG - Bulgaria 11
SC - Seychelles 11
BS - Bahamas 10
DO - Repubblica Dominicana 10
SK - Slovacchia (Repubblica Slovacca) 10
BH - Bahrain 9
HU - Ungheria 9
NG - Nigeria 9
SN - Senegal 9
Totale 79.763
Salva come PNG Salva come JPEG
Città #
Dublin 3.875
Chandler 3.752
San Jose 3.590
Jacksonville 3.150
Ashburn 2.666
Nanjing 2.580
Singapore 2.430
Dallas 2.061
Hong Kong 2.056
Beijing 1.834
Council Bluffs 1.786
Boardman 1.133
Nanchang 1.046
Munich 834
Princeton 824
Helsinki 800
Wilmington 771
Los Angeles 761
Hebei 755
Lawrence 752
Shenyang 747
Lauterbourg 699
Changsha 683
Jiaxing 602
Ho Chi Minh City 577
New York 565
Medford 548
Tianjin 443
Hangzhou 430
Ann Arbor 429
Hanoi 413
Moscow 351
Johannesburg 335
Shanghai 329
Milan 328
Buffalo 320
Redondo Beach 303
Santa Clara 262
Toronto 246
São Paulo 207
Dearborn 194
Woodbridge 187
Turku 178
Tokyo 170
Orem 164
Norwalk 156
Pavia 139
Montreal 129
Fairfield 123
Warsaw 122
Houston 118
Brooklyn 114
Atlanta 112
Verona 109
San Francisco 108
Chicago 107
Frankfurt am Main 107
Brussels 104
Seattle 103
Rome 102
Pune 99
Chennai 96
Da Nang 87
Phoenix 81
London 79
Guangzhou 74
Kunming 73
Baghdad 72
Denver 71
Jinan 69
Falkenstein 67
Stockholm 62
Rio de Janeiro 61
Boston 60
Des Moines 60
Haiphong 59
The Dalles 59
San José 58
Brno 56
Amsterdam 55
Mexico City 55
Zhengzhou 53
Turin 50
Naples 49
Ningbo 49
Quito 49
Amman 48
Ankara 48
Cambridge 48
Tashkent 48
Manchester 47
North Bergen 47
Washington 46
Columbus 44
Poplar 44
San Salvador 44
Biên Hòa 43
Willemstad 43
Palermo 41
Managua 40
Totale 51.253
Salva come PNG Salva come JPEG
Nome #
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 620
A new "three seamples" method to detect lactose malabsorption by H2 breath testing 310
A gluten-free diet questionnaire compared to persistence of villous atrophy and endomysial antibody. 301
A gluten-free diet questionnaire compared to persistence of villous atrophy and endomysial antibody 293
Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease 273
Rugarli - Medicina interna sistematica - Malattie dell'apparato digerente 260
Peripheral blood dendritic cells in coeliac disease 231
A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions 231
Study of the microbiota composition in adult celiac disease 224
Harrison Principi di Medicina Interna, 18a Edizione 195
A consensus for the development of a vector model to assess clinical complexity 192
A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. 190
A new approach to diagnosis of intestinal graft-versus-host disease by transabdominal high-resolution ultrasonography and colour doppler imaging 187
Clinical response to gluten withdrawal is not an indicator of coeliac disease. 185
Infliximab e marker sierici di fibrosi nel morbo di Crohn. 181
Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 179
Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease 177
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas. 175
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 172
Cytokine genetic profile in Whipple's disease 172
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 172
Long-Term Natural History of Autoimmune Gastritis: Results From a Prospective Monocentric Series 171
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 170
Anemia and erythropoiesis in untreated coeliac disease 168
Malattia di Crohn fistolizzante - Nuovo approccio terapeutico con le cellule staminali 167
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 167
A milligram of gluten a day keeps the mucosal recovery way 167
Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome. 164
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 164
A double colour immuno-fluorescence co-localization study of EMA+ve/TTA-ve coeliac sera and anti-tTG moAb 163
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 163
Abnormal post-prandial glucagon-like peptide release in patients with Crohn's disease 162
La malattia celiaca 161
Induzione e mantenimento di remissione clinica mediante l’utilizzo di Budesonide in paziente affetto da malattia di Crohn ad esordio giovanile, a localizzazione ileo-colonica e fenotipo steno-fistolizzante, già sottoposto a terapia immunosoppressiva, biologica, cellulare e chirurgica. 161
Metalloproteinasi di matrice e tratto gastrointestinale 157
A non-toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? 156
Abnormal anandamide metabolism in celiac disease. 156
Intraepithelial lymphocytes in the villous tip: do they indicate potential coelic disease? 155
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. 155
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma 155
A laboratory score in the diagnosis of autoimmune atrophic gastritis: A prospective study 154
Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy? 153
Le cellule staminali quale potenziale strategia terapeutica nelle malattie infiammatorie croniche 153
Immunosuppressive effect of bone marrow-derived mesenchymal stromal cells on gliadin-specific T cell lines 153
A comparison of the screening power of endomysial and tissue transglutaminase antibodies in coeliac disease 153
The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy: a follow-up study. 152
Effect of tumor necrosis factor-alpha blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease 152
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 152
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease. 151
Malattia di Crohn: novità e prospettive della terapia. 151
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 150
A case of fever of unknown origin? 149
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 148
A non toxic analogue of a coeliac-activating gliadin peptide: a basis for immunomodulation? 148
A reassessment of splenic hypofunction in celiac disease. 147
A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. 147
Validation and cross-cultural adaptation of the Italian translation of the Inflammatory Bowel Disease Questionnaire in patients with Crohn's disease or Ulcerative Colitis. 146
Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: Analysis of 200 cases with extended follow-up 146
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 145
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 145
Correlation between mucosal levels of receptor for advanced glycation end products (RAGE) with inflammatory indexes in crohn's disease and ulcerative colitis 144
Increased expression of mucosal addressin cell adhesion molecule-1 in the duodenum of patients with active celiac disease is associated with depletion of integrin α4β7-positive T cells in blood. 144
Coeliac disese in first degree relatives: an incidence study 143
Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease 143
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease. 142
Mitochondrial dysfunction in Crohn disease: possible role of reactive oxygen species 142
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease 142
Aquaporins and solute transporters are decreased in coeliac disease 141
HLA DQ2 and DQ8 homozygosity in patients with potential coeliac disease 141
Bone mass and metabolism in dermatitis herpetiformis 140
Doppler enhancement after intravenous levovist injection in Crohn's disease 140
A one minute questionnaire to evaluate the compliance to a gluten-free diet. 139
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 139
Cerebellar signs in celiac disease. 139
A comparison of the screening power of endomysial and tissue transglutaminase antibodies in coeliac disease 139
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 139
Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas 139
A milligram of gluten a day keeps the mucosal recovery away: a case report. 138
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 138
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 138
Apoptosis and peripheral blood lymphocyte depletion in coeliac disease. 137
Phenotypical and functional characterization of bone marrow-derived mesenchymal stromal cells from patients with Crohn’s disease 137
Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome. 137
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 137
Absence of a role for interleukin-13 in inflammatory bowel disease 137
Herbay classification applied to Italian patients with Whipple's disease 136
Manuale di Gastroenterologia UNIGASTRO Coordinamento Nazionale Docenti Universitari Malattie dell’Apparato Digerente 136
Bones in coeliac disease: diagnosis and treatment 135
Genetic test for lactase non-persistence and hydrogen breath test: is genotype better than phenotype to diagnose lactose malabsorption? 135
IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients. 135
An Italian multicentric study on complicated coeliac disease 135
From impending toxic megacolon to multiple organ failure in severe ulcerative colitis 135
IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients 135
Decreased Serum Levels Of Soluble Receptor For Advanced Glycation End Products Inversely Correlate With Disease Activity Indexes In Patients With Inflammatory Bowel Disease 135
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 135
HLA clas I and II in patients with Whipple's disease 134
An unconventional case of scurvy. 134
Comparative Study of Salivary, Duodenal, and Fecal Microbiota Composition Across Adult Celiac Disease 134
The incidence of coeliac disease in adult first degree relatives. 133
Bortezomib-induced paralytic ileus is a potential gastrointestinal side-effect of this first-in-class anti-cancer proteasome inhibitor 133
Totale 16.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 339.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 339.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.883 0 0 0 0 34 48 54 197 172 116 556 1.706
2022/202311.118 1.283 849 104 748 1.146 1.089 56 643 4.648 127 279 146
2023/20243.690 521 639 111 281 354 1.038 75 262 20 130 131 128
2024/202510.931 224 896 362 404 205 621 630 874 2.656 307 1.157 2.595
2025/202624.502 1.907 1.633 2.762 2.577 2.845 1.102 4.894 1.085 2.233 1.844 843 777
2026/20276.803 862 1.342 1.508 2.814 277 0 0 0 0 0 0 0
Totale 80.952